Programs
There are a number of programs and initiatives aimed at increasing the competitiveness of the United States manufacturing sector. These programs support, supplement, and integrate with the needs of manufacturers to provide the tools needed to succeed.
-
Biomedical Advanced Research and Development Authority – Pharmaceutical Countermeasures Infrastructure (PCI)
A strong, committed partnership between industry and the federal government is vital when responding to a public health emergency. Through the work of its three programs, the Pharmaceutical Countermeasures Infrastructure (PCI) partners with industry to strengthen and enhance the nation’s ability to manufacture, distribute, and administer life-saving vaccines and therapeutics during a public health emergency.
-
Materials Genome Initiative
Agencies:Department of Defense (DoD), Department of Energy (DOE), Department of Health and Human Services (DHHS), Department of the Interior (DOI), National Institute of Standards and Technology (NIST), National Institutes of Health (NIH), National Science Foundation (NSF)The Materials Genome Initiative is a federal multi-agency initiative for discovering, manufacturing, and deploying advanced materials twice as fast and at a fraction of the cost compared to traditional methods. The initiative creates policy, resources, and infrastructure to support U.S. institutions in the adoption of methods for accelerating materials development.
-
National Biopharmaceutical Manufacturing Preparedness Consortium (BioMap-Consortium)
The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) supports the Biomedical Advanced Research and Development Authority (BARDA) and is comprised of industry partners across the drug and vaccine manufacturing supply chain, including manufacturers of required raw materials and consumables, developers of innovative manufacturing technologies, and suppliers of fill finish services. This consortium seeks to expand the industrial and manufacturing base for medical countermeasures to include the requisite capabilities, flexibilities, and strategies to secure needed medical supplies to meet the nation’s public health preparedness and response requirements.